Drug firm Wockhardt today said it has received final approval from the US health regulator to market generic Fluticasone nasal spray, used for treating allergic nasal inflammation, in the American
Drug firm Wockhardt plans to launch 12-15 products in the US market this fiscal and also increase its reach in the European market.
"The company received 7 abbreviated new drug
Wockhardt expects to complete divestment of its nutrition business by the end of this financial year. The company said it has reached agreement with EU based secured lenders
Drug firm Wockhardt today posted a consolidated net profit of Rs 194 crore for the first quarter ended June 30, 2011.
The company had reported a net loss of Rs
Pharma major Wockhardt on Friday said it has received tentative approval from the US health regulator to market generic Duloxetine Hydrochloride capsules, used for treating depression, in the American market.
Drug maker Wockhardt today said it has received tentative approval from the US health regulator to market Olopatadine hydrochloride eye drops in the American market.
The company has received approval
Pharmaceutical and biotech firm Wockhardt Ltd today said it has received tentative approval from the US health regulator to sell a generic copy of Aricept tablets, used in the treatment
Indian pharma firm Wockhardt said on Tuesday that it has received approval of the USFDA to sell a version of Pfizer’s anti-depressant drug Effexor’s extended release capsules. The drug, Venlafaxine,
Stay informed on our latest news!
